Premature ovarian failure: genes and variants
Explore variant evidence for Premature ovarian failure across 4 analyzed proteins (NOS3, CHEK2, FMR1, XRCC2). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 15 variants of uncertain significance and 14 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Premature ovarian failure
NOS3: Nitric oxide synthase 3
It generates nitric oxide in vascular endothelium, promoting smooth-muscle relaxation, inhibiting platelet activation, and supporting vascular homeostasis. Reduced activity contributes to endothelial dysfunction, while common genetic variation has modest effects on cardiovascular traits.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NOS3 have source records linked to Premature ovarian failure. Association strength is not clinical gene validity.
CHEK2: Serine/threonine-protein kinase Chk2
It propagates DNA-damage checkpoint signals to proteins controlling cell-cycle arrest, repair, and apoptosis. Germline loss-of-function variants confer moderate cancer susceptibility, especially for breast cancer, while risk estimates depend on the specific allele and family context.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CHEK2 have source records linked to Premature ovarian failure. Association strength is not clinical gene validity.
FMR1: Fragile X messenger ribonucleoprotein 1
Its FMRP product binds neuronal RNAs and regulates their transport and local translation at synapses. Full CGG-repeat expansion silences the gene and causes fragile X syndrome, while premutation alleles can cause tremor-ataxia syndrome or primary ovarian insufficiency.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in FMR1 have source records linked to Premature ovarian failure. Association strength is not clinical gene validity.
XRCC2: DNA repair protein XRCC2
It acts with other RAD51 paralogs to assemble and stabilize homologous-recombination repair machinery at DNA double-strand breaks. Biallelic loss-of-function variants can cause Fanconi-anemia-like chromosome-instability disease, while heterozygous cancer-risk associations are less certain.
0 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in XRCC2 have source records linked to Premature ovarian failure. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): RYR3, BRD3, C3, CHD7, CYP17A1, CYP19A1, FANCC, GALT and 9 more.
ClinVar pathogenic and likely pathogenic variants linked to Premature ovarian failure
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CHEK2 Y390S | 390 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| NOS3 E169K | 169 | Interaction with NOSIP | Pathogenic / likely pathogenic (★) |
| NOS3 P58S | 58 | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- CHEK2-related cancer predisposition also has ClinVar records linked to CHEK2 variants; they fall mostly in different places as the Premature ovarian failure variants (3 pathogenic / likely pathogenic).
- Hereditary breast cancer also has ClinVar records linked to CHEK2 variants; they fall mostly in different places as the Premature ovarian failure variants (3 pathogenic / likely pathogenic).
Diseases related to Premature ovarian failure
- Lynch syndrome, also linked to CHEK2
- Li-Fraumeni syndrome, also linked to CHEK2
- Fanconi anemia complementation, also linked to XRCC2
- Hereditary breast cancer, also linked to CHEK2
- Hereditary breast ovarian cancer syndrome, also linked to CHEK2
- Fanconi anemia, also linked to XRCC2
- Colorectal cancer, also linked to CHEK2
- Gastric cancer, also linked to CHEK2
- Breast and/or ovarian cancer, also linked to CHEK2
- Bone osteosarcoma, also linked to CHEK2
- Prostate cancer, also linked to CHEK2
- CHEK2-related cancer predisposition, also linked to CHEK2
Frequently asked questions
Which genes have records linked to Premature ovarian failure?
This view contains 4 analyzed proteins: NOS3, CHEK2, FMR1, XRCC2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 15 variants of uncertain significance and 14 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 37 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center